The Latest in Corneal Degenerations and Dystrophies Corneal

Total Page:16

File Type:pdf, Size:1020Kb

The Latest in Corneal Degenerations and Dystrophies Corneal 5/20/2014 Epithelial (Anterior) Basement Membrane CORNEAL DEGENERATION Dystrophy (EBMD or ABMD) • Non-familial, late onset • Easy to overlook: The Latest In Corneal • Asymmetric, unilateral, central or peripheral – typically bilateral though often asymmetric, Degenerations and Dystrophies • Changes to the tissue caused by inflammation, – females>males, age, or systemic disease. – often first diagnosed b/w ages of 40-70 Blair B Lonsberry, MS, OD, MEd., FAAO Characterized by a deposition of material, a Diplomate, American Board of Optometry • Clinic Director and Professor thinning of tissue, or vascularization Pacific University College of Optometry Portland, OR [email protected] Epithelial (Anterior) Basement Membrane Epithelial (Anterior) Basement Membrane Dystrophy (EBMD or ABMD) Dystrophy (EBMD or ABMD) • Most common • Primary features of this “dystrophy” are: findings are: – abnormal corneal epithelial regeneration and – chalky patches, maturation, – intraepithelial – abnormal basement membrane microcysts, and • Often considered the most common dystrophy, – fine lines (or any but may actually be an age-related degeneration. combination) in the central 2/3rd of CORNEAL DYSTROPHIES – large number of patients with this condition, cornea – increasing prevalence with increasing age, and – its late onset support a degeneration vs. dystrophy. 2 2 8 Epithelial (Anterior) Basement Membrane Epithelial (Anterior) Basement Membrane Corneal Dystrophies Dystrophy (EBMD or ABMD) Dystrophy (EBMD or ABMD) • Group of corneal diseases that are: • Not all patients are symptomatic (range 10- • Often referred to as: – maps, – genetically determined and 69%) • Most common symptom is mild FB sensation – dots or – have been traditionally classified with respect to – fingerprints the corneal layer affected which is worse in dry weather, wind and air conditioning • Emerging molecular science: • Blurred vision from irregular astigmatism or is redefining traditional thought on the – rapid TBUT dystrophies and • Pain is usually secondary to a RCE (recurrent – offering potential avenues for therapeutic intervention. corneal erosion) in apprx 10% 9 1 5/20/2014 Recurrent Corneal Erosion: EBMD-Negative Staining Treatment Amniotic Membrane Transplant • If severe enough to cause vision loss or • Amniotic membrane is a biologic tissue with: repeated episodes: – antiangiogenic, – antiscarring, • oral doxycycline with/without topical corticosteroid – antimicrobial, and – Doxy 50 mg bid and FML tid for 4-8 weeks – anti-inflammatory properties that promotes healing of the ocular – both meds inhibit key metalloproteinases important in surface disease pathogenesis • Amniotic membrane grafts have been used for a variety of ocular – Azasite (topical azithromycin) conditions including: – Corneal burns • debridement, – Neurotrophic ulcers • stromal puncture, or – Stem cell damage • PTK – Persistent epithelial defects • Latest development: amniotic membrane transplant e.g. Prokera Epithelial (Anterior) Basement Membrane Dystrophy (EBMD or ABMD): Treatment Stromal Puncture Amniotic Membrane Transplant • Typically directed towards • Traditionally, amniotic membrane grafts had to be preventing RCE sutured • If RCE ’s develop: – With the advent of tissue adhesives, amniotic transplants – awake with painful eye can now be sutureless that improves as day • ProKera was approved by the FDA in 2003 as a Class II wears on medical device which has a polycarbonate ring which – chalky patches/dots in holds a cryopreserved amniotic membrane lower 2/3rd of cornea • ProKera is indicated in the treatment of corneal erosions, neurotrophic corneas, recalcitrant corneal inflammation, acute ocular surface burns, acute Stevens Johnson syndrome, and descemetoceles. RCE: Treatment CORNEAL DEBRIDEMENT RCE and LASIK • Soften epithelium • Initial treatment • 1-2 gtt topical anesthetic • Patients who have a history of EBMD may not includes: • q 15-30 seconds for 2-3 be ideal candidates for LASIK and should be minutes – use of hyperosmotic • Use cotton swab, spatula, spud carefully screened for prior to surgery. ointment at • or jewelers forceps • Remove flaps by pulling edges bedtime, toward center – bandage contact • Don ’t pull directly up or out lens and • Remove flaps down to tight, • firm edges. – lubrication. • Tx abrasion (>50-100%) – Recurrence Rate 18% 12 18 2 5/20/2014 Granular Dystrophy: Macular (Groenouw Type II) Lattice (Type I) (Groenouw Type I) • Grayish opacities in • RCE are common with • The central cornea is the superficial stroma associated pain. progressively opacified resulting is scarring and • With age: • Decreased vision results deterioration of vision – extension into deeper from subepithelial while the periphery stromal layers scarring or dense stromal remains clear. – intervening stroma deposits. • RCE ’s often present. becomes hazy • Surgical treatment • May require surgical – progressive loss of includes penetrating intervention with vision, keratoplasty or DALK diminished vision. – photophobia and (Deep Anterior Lamellar – PK ocular discomfort. Keratoplasty). – DALK 22 25 Central Crystalline Dystrophy of Macular Corneal Dystrophy PTK Treatment for GRANULAR Schnyder • Surgical treatment • Opacities consist of: usually required by – small, needle-shaped 2nd or 3rd decade of refractile crystals life. that are either white or polychromatic – PK – may extend into – DALK not indicated deeper stroma but as may have damage epithelium remains to Descemets normal. SCLAFANI 26 Granular Dystrophy: Central Crystalline Dystrophy of Lattice (Type I) (Groenouw Type I) Schnyder • Discrete white • Characteristic clinical granular opacities in central anterior appearance includes: • Vision is typically mildly affected though there corneal stroma. – linear, maybe associated systemic complications • With age: – refractile, – systemic cholesterol should be evaluated – increasing number, density, size and depth – branching deposits of opacities within the anterior – intervening stroma stroma. and peripheral cornea remain clear 3 5/20/2014 Penetrating Keratoplasty Deep Anterior Lamellar Keratoplasty (DALK) • Advantages over PK: – No “open sky” during surgery so lesser chance of expulsive hemorrhage – Much decreased rejection potential because patient keeps their own endothelium • Stromal rejection is rare and easily treated – Low to no rejection risk so steroids are tapered more quickly (usually twice as fast) – Heals faster as steroids tapered sooner allowing sutures to be SURGICAL TREATMENTS: PK AND removed earlier and more rapid visual stabilization (apprx 6 DALK months) – More tectonic stability as patient keeps own endo PK Surgery: Full Thickness Surgery Deep Anterior Lamellar Keratoplasty (DALK) Normal Changes to the Endothelium • Removal of all tissue EXCEPT Descemet ’s and • Descemet ’s layer thickens from 3-17u Donor tissue Recipient tissue sutured into endothelium • There is a decrease in the # of endothelial removed recipient – Most common rejection seen in PK is endothelial cells Central trephine cut rejection observed in apprx 20% of low-risk cases – from 3500 cells/mm2 to 1200 made ’ – Repeated PK s increase chance that the graft will – this single layer spreads out: lacks mitosis be rejected • High density mitochondria : 90% pump – DALK can avoid risk of endothelial rejection with similar optical results as PK • Lenses produce reversible polymegathism Full thickness block Sutures create an Smooth Surface with only of tissue removed just irregular surface endothelial disease to get to the endothelium with astigmatism and blurring SCLAFANI Deep Anterior Lamellar Keratoplasty (DALK) Abnormal Changes to the Endothelium • Indicated for patients with • Endothelial cells become more irregular – Keratoconus • Cells secrete collagen – Corneal scars towards Descemet’s – Corneal stromal dystrophies causing multilamination – Basically any pathology that spares the = guttata endothelium • This breaks down the • Contraindicated barrier function and results in stromal and – Bullous keratopathy epithelial edema – Fuch’s SCLAFANI 4 5/20/2014 Fuch ’s Dystrophy Fuch ’s Dystrophy: Guttata Fuch ’s Dystrophy • Endothelium: • Patient symptoms vary with degree of guttata – acts as both a barrier and pump function and compromised pump function – responsible for maintaining corneal transparency • Moderate guttata by reducing corneal hydration – may affect visual function • Fuch ’s: – may result in light scatter (haloes) – typically noticed upon waking – occurs bilaterally, • With increased disruption to the pump: – AD inheritance, – vision decreases – females 3x more likely to develop condition – potential development of bullous keratopathy Fuch ’s Dystrophy: Guttata • Corneal guttata Healthy endo: Cornea Thin and clear Endo dropout: Cornea swells, mild vision loss – excessive accumulation of abnormal endo secretions is associated with the disease process – usually first noticed in the central cornea in the patients 30 ’s and 40 ’s – corneal physiology is affected adversely by interference with pump action – guttata appear as small refractile “drops ” on the Severe swelling, blisters on surface, Va drops, pain Chronic swelling, surface scarring corneal endo Normal Endothelial Mosaic Stages of Fuch ’’’s Dystrophy Fuch ’s Dystrophy: Guttata Fuch ’s: Bullous Keratopathy • closer inspection with specular reflection reveals an “orange peel-like ” dimpling of the endo • with the decreased pump function, the overlying stroma becomes edematous • long standing corneal edema may result in corneal
Recommended publications
  • Understanding Corneal Blindness
    Understanding Corneal Blindness The cornea copes very well with minor injuries or abrasions. If the highly sensitive cornea is scratched, healthy cells slide over quickly and patch the injury before infection occurs and vision is affected. If the scratch penetrates the cornea more deeply, however, the healing process will take longer, at times resulting in greater pain, blurred vision, tearing, redness, and extreme sensitivity to light. These symptoms require professional treatment. Deeper scratches can also cause corneal scarring, resulting in a haze on the cornea that can greatly impair vision. In this case, a corneal transplant may be needed. Corneal Diseases and Disorders that May Require a Transplant Corneal Infections. Sometimes the cornea is damaged after a foreign object has penetrated the tissue, such as from a poke in the eye. At other times, bacteria or fungi from a contaminated contact lens can pass into the cornea. Situations like these can cause painful inflammation and corneal infections called keratitis. These infections can reduce visual clarity, produce corneal discharges, and perhaps erode the cornea. Corneal infections can also lead to corneal scarring, which can impair vision and may require a corneal transplant. Fuchs' Dystrophy. Fuchs' Dystrophy occurs when endothelial cells gradually deteriorate without any apparent reason. As more endothelial cells are lost over the years, the endothelium becomes less efficient at pumping water out of the stroma (the middle layers of the cornea). This causes the cornea to swell and distort vision. Eventually, the epithelium also takes on water, resulting in pain and severe visual impairment. Epithelial swelling damages vision by changing the cornea's normal curvature, and causing a sightimpairing haze to appear in the tissue.
    [Show full text]
  • Peripheral Hypertrophic Subepithelial Corneal Degeneration Presenting
    Eye (2015) 29, 88–97 & 2015 Macmillan Publishers Limited All rights reserved 0950-222X/15 www.nature.com/eye 1,2 3 4 CLINICAL STUDY Peripheral MSchargus , C Kusserow ,USchlo¨ tzer-Schrehardt , C Hofmann-Rummelt4, G Schlunck1 hypertrophic and G Geerling1,5 subepithelial corneal degeneration presenting with bilateral nasal and temporal corneal changes Abstract 1 Department of Purpose To characterise the history, clinical transmission electron microscopy showed Ophthalmology, University of Wuerzburg, Wuerzburg, and histopathological features of patients histological features that are similar to Germany with bilateral nasal and temporal peripheral Salzmann’s corneal changes without any hypertrophic subepithelial corneal inflammation. We hypothesise that light 2Department of degeneration in a German population. exposure and a localised limbal insufficiency Ophthalmology, University Methods A detailed ophthalmological and could be involved in the pathogenesis. of Bochum, Bochum, dermatological history and clinical findings Eye (2015) 29, 88–97; doi:10.1038/eye.2014.236; Germany were recorded of nine patients with bilateral published online 3 October 2014 3Department of simultaneous nasal and temporal peripheral Ophthalmology, University corneal degeneration from two centers in of Luebeck, Lu¨ beck, Germany. Excised tissues were studied by Introduction Germany histopathology, immunohistochemistry, and transmission electron microscopy. Salzmann’s nodules (SN) are subepithelial, 4 Department of Results Foreign body sensation and need elevated bluish-white corneal opacities of non- Ophthalmology, University inflammatory origin, with a specific peripheral of Erlangen-Nuernberg, of artificial tear substitutes were the only 1–7 Erlangen, Germany symptoms reported regularly. Schirmer’s and circular pattern. What has been termed Jones-test were normal in all, but fluorescein Salzmann’s degeneration is predominantly 5Department of break-up time of 410 s was found in five eyes unilateral, presenting at any time in life with Ophthalmology, University of four patients.
    [Show full text]
  • Its Not Just Dry Eye NCOS2021
    5/31/21 DISCLOSURES CORNEA ENDOTHELIOPATHIES NOPE, THAT’S NOT JUST DRY EYE: PRIMARY SECONDARY OTHER CORNEAL DISEASES • Corneal guttata • Contact lens wear • Fuchs dystrophy • Surgical procedures • Posterior Polymorphous Dystrophy (PPD) • Age related Cecelia Koetting, OD FAAO • Congenital hereditary endothelial dystrophy • Iatrogenic (im munodeficiency) (CHED) • Glaucoma induced Virginia Eye Consultants • Iridocorneal endothelial syndrome (ICE) • Ocular inflammation Norfolk, VA 1 2 3 OTHER CORNEAL CORNEAL FUNCTION • Keratoconus • Central cloudy dystrophy of Francois • Pellucid marginal degeneration • Thiel-Behnke corneal dystrophy • Shields the eye from germs, dust, other harmful matter • Lattice Dystrophy • Ocular Bullous pemphigoid WHY IS THE CORNEA IMPORTANT? • Contributes between 65-75% refracting power to the eye • Recurrent corneal erosion (RCE) • SJS • Filters out some of the most harmful UV wavelengths • Granular corneal dystrophy • Band Keratopathy • Reis-Bucklers corneal dystrophy • Corneal ulcer • Schnyder corneal dystrophy • HSV/HZO • Congenital Stromal corneal dystrophy • Pterygium • Fleck corneal dystrophy • Burns/Scars • Macular corneal dystrophy • Perforations • Posterior amorphous corneal dystrophy • Vascularized cornea 4 5 6 CORNEAL ANATOMY CORNEA Epithelium Bowmans Layer • Cornea is a transparent, avascular structure consisting of 6 layers • A- Anterior Epithelium: non-keratinized stratified squamous epithelium; cells migrate from BRIEF ANATOMY REVIEW Stroma basal layer upward and periphery to center • B- Bowmans Membrane:
    [Show full text]
  • Bilateral Cataract Surgery in Posterior Polymorphous Corneal Dystrophy
    J Clin Case Rep Trials 2018 Journal of Volume 1: 1 Clinical Case Reports and Trials Bilateral Cataract Surgery in Posterior Polymorphous Corneal Dystrophy Taha Ayyildiz1* 1Department of Ophthalmology, Ahi Evran University, Kırsehir, Turkey Abstract Article Information Posterior polymorphous corneal dystrophy (PPCD) is an autosomal Article Type: Case Report dominant corneal dystrophy and usually non-progressive which is Article Number: JCCRT101 characterized by metaplasia and excessive growth of the corneal Received Date: 06th-March -2018 endothelium and Descemet’s membrane defects. Biomicroscopic slit Accepted Date: 14th-April -2018 Published Date: 19th-April -2018 lesions are observed. The patients are usually asymptomatic corneal edemalamp examination was observed shows in some isolated advanced or confluent cases. The vesicles evaluation and ofbands 38-year- like *Corresponding author: Dr. Taha Ayyildiz, Department old male patient who admitted to our clinic and it was observed every of Ophthalmology, Ahi Evran University, Kırsehir, Turkey. 2 cornea PPCD that the accompanying dense nuclear sclerosis cataracts. Tel: +90-386-280-42-00; E-mail: [email protected] In this study, we aimed to share the results of uncomplicated cataract surgery. Citation: Ayyildiz T (2018) Bilateral Cataract Surgery in Posterior Polymorphous Corneal Dystrophy. J Clin Case Keywords: Rep Trials. Vol: 1, Issu: 1 (01-03). dystrophy. Phacoemulsification, Cataract, Posterior polymorphous Copyright: © 2018 Ayyildiz T. This is an open-access Introductıon article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the Koeppé in 1916 withwide corneal and anterior segment anomaly [1]. It original author and source are credited.
    [Show full text]
  • Familial Pathologic Myopia, Corneal Dystrophy, and Deafness: a New Syndrome
    Familial Pathologic Myopia, Corneal Dystrophy, and Deafness: A New Syndrome Emin Kurt*, Abdullah Günen†, Yılmaz Sadıkog˘ lu†, Faruk Öztürk*, Serdar Tarhan‡, Refik Ali Sarı§, Tevhide Fıstıkʈ and Zeki Arı¶ Departments of *Ophthalmology, †Otorhinolaryngology, ‡Radiology, §Internal Medicine, ʈMedical Genetics, and ¶Biochemistry, School of Medicine, University of Celal Bayar, Manisa, Turkey Background: Numerous syndromes with myopia and hearing loss have been described up to now. We present a family with pathologic myopia, corneal dystrophy, and deafness distinct from these syndromes. Cases: Ten patients in the same Turkish family were evaluated by ophthalmologic, audio- logic, physical, radiologic, genetic, serologic, and biochemical examinations. Observations: Ophthalmic examination indicated that all the cases had myopia, 7 of them had pathologic myopia, 1 had intermediate, and 2 had mild. Four of the patients with patho- logic myopia had corneal dystrophy that was bilaterally manifest as white opacities in the posterior stroma near Descemet’s membrane in an axial distribution; 1 of these 4 patients also had a tilted disc. Otolaryngologic examination revealed conductive hearing loss in 3 cases, mixed hearing loss in 2, and sensorineural hearing loss in 1. The results of karyotypic analyses of all cases were normal. The pedigree analysis showed the disease was inherited through successive generations as an autosomal dominant trait. The results of biochemical, serologic, and radiologic investigations were normal. The same pathophysiologic process in all cases seemed to account for the myopia, the corneal dystrophy and the deafness. Conclusions: To our knowledge, this type of case has not been reported in the literature. Therefore, we named this syndrome “familial pathologic myopia, corneal dystrophy and deafness.” Jpn J Ophthalmol 2001;45:612–617 ©2001 Japanese Ophthalmological Society Key Words: Corneal dystrophy, hearing loss, pathologic myopia, tilted disc, syndrome.
    [Show full text]
  • Avellino Corneal Dystrophy After LASIK
    Avellino Corneal Dystrophy after LASIK Roo Min Jun, MD,1,4 Hungwon Tchah, MD,2 Tae-im Kim, MD,2 R. Doyle Stulting, MD, PhD,3 Seung Eun Jung, MS,4,6 Kyoung Yul Seo, MD,4 Dong Ho Lee, MD,5 Eung Kweon Kim, MD, PhD4,6 Objective: To report cases of Avellino corneal dystrophy (ACD) exacerbated by LASIK for myopia. Design: Retrospective, noncomparative, interventional case series and review of the literature. Participants: Seven patients. Intervention: Six patients with exacerbation of granular corneal deposits after LASIK were examined for TGFBI mutations by polymerase chain reaction sequencing of DNA. One previously reported patient who was heterozygous for the ACD gene was followed up for 16 months after mechanical removal of granular deposits from the interface after LASIK. Main Outcome Measures: Slit-lamp examination, visual acuity, manifest refraction, and DNA sequencing analysis. Results: All patients were heterozygous for the Avellino dystrophy gene. Corneal opacities appeared 12 months or more after LASIK. Best spectacle-corrected visual acuity decreased as the number and density of the opacities increased. One patient underwent mechanical removal of granules from the interface and had a severe recurrence within 16 months. Another patient had removal of the granules from the interface with PTK, followed by treatment with topical mitomycin C. In this patient, the cornea has remained relatively clear for 6 months. Conclusions: Laser in situ keratomileusis increases the deposition of visually significant corneal opacities and is contraindicated in patients with ACD. Mechanical removal of the material from the interface does not prevent further visually significant deposits. Mitomycin C treatment, in conjunction with surgical removal of opacities, may be an effective treatment.
    [Show full text]
  • The Outcome of Penetrating Keratoplasty for Corneal Scarring
    ORIGINAL ARTICLE The outcome of penetrating keratoplasty for corneal scarring due to herpes simplex keratitis O resultado da ceratoplastia penetrante para cicatriz de córnea consequente à ceratite por herpes simplex YESIM ALTay1, SEMA TAMER1, ABDULLAH SENCER Kaya1, OZGUR BALTA1, AYSE BURCU1, FIRDEVS ORNEK1 ABSTRACT RESUMO Purpose: To determine the outcomes of penetrating keratoplasty (PK) for treatment Objetivo: Determinar os resultados da ceratoplastia penetrante (PK) para o trata- of corneal scarring caused by Herpes simplex virus (HSV) keratitis, and whether mento da cicatriz da córnea consequente à ceratite por Herpes simplex vírus (HSV), the corneal scar type affects treatment outcome. e se o tipo de cicatriz na córnea afeta o resultado cirúrgico. Methods: A retrospective analysis of patients who underwent PK for HSV-related Métodos: Foi realizada análise retrospectiva dos pacientes, submetidos à PK para corneal scarring between January 2008 and July 2011 was performed. The patients a cicatriz da córnea relacionados com o HSV entre janeiro de 2008 e julho de 2011. were categorized into two groups. Group 1 consisted of patients with a quiescent Os pacientes foram divididos em dois grupos. Grupo 1 consistiu de pacientes que herpetic corneal scar and group 2 consisted of patients who developed a corneal tiveram cicatriz corneana herpética quiescente e grupo 2 consistiu de pacientes que descemetocele or perforation secondary to persistent epithelial defects with no desenvolveram descemetocele ou perfuração córnea secundária a defeitos epiteliais active stromal inflammation. The mean follow-up was 21.30 ± 14.59 months. The persistentes sem inflamação estromal ativa. O seguimento médio foi de 21,30 ± 14,59 main parameters evaluated were recurrence of herpetic keratitis, graft rejection, meses.
    [Show full text]
  • Coincident Pellucid Marginal Degeneration and Fuchs’ Endothelial Dystrophy 1James Mckelvie, 2Cameron Andrew Mclintock, 3Samer Hamada
    IJKECD James McKelvie et al. 10.5005/jp-journals-10025-1170 CASE REPORT Coincident Pellucid Marginal Degeneration and Fuchs’ Endothelial Dystrophy 1James McKelvie, 2Cameron Andrew McLintock, 3Samer Hamada ABSTRACT BACKGROUND Aim: We report a rare case of coincident pellucid marginal Pellucid marginal degeneration (PMD) is a rare, bilateral, degeneration and Fuchs’ endothelial dystrophy. non-inflammatory corneal ectatic disorder characterized 1 Background: As far as the authors are aware there have been by a band of inferior corneal thinning. PMD has a 3:1 male no previous reports of this combination of corneal disorders predominance and typically presents between the ages of in the same patient. 20–50 years with declining vision, irregular astigmatism, and inferior steepening and thinning noted on corneal Case description: A 45-year-old woman presented with tomography.2-4 Fuchs’ endothelial corneal dystrophy (FECD) progressive pellucid marginal degeneration and Fuchs’ endo- thelial dystrophy. Progressive changes in corneal topography is the most common corneal dystrophy and the most common 5 and specular microscopy imaging have been documented dystrophy-related indication for corneal transplantation. over 13 years since presentation. Declining vision has been FECD is characterized by progressive loss of corneal endothe- successfully managed in this patient, to date, with serial cres- lial cells, a formation of guttae and decreased vision typically centic corneal wedge excision biopsies to maintain acceptable associated with corneal edema.6 In contrast to PMD, FECD spectacle-corrected visual acuity. has a 2.5–3:1 female predominance and presentation is typi- Conclusion: This rare combination of corneal disorders pre- cally either as an early onset subtype in the third decade, or 5 sents an interesting and unique challenge for surgical manage- a late onset subtype in the fifth decade of life.
    [Show full text]
  • Effects of Intracameral Cefuroxime on Corneal Endothelial Cell Counts and Its Morphology After Cataract Surgery
    Interventional Medicine & Applied Science, Vol. 9 (2), pp. 100–104 (2017) ORIGINAL PAPER Effects of intracameral cefuroxime on corneal endothelial cell counts and its morphology after cataract surgery KOUROSH SHAHRAKI1, MOHAMMAD NAEIM AMINI FARD1,*, FARKHONDEH SHAHRI2, RAMA POURMATIN3, TAFGEH MOHAMMADI1, PARIA GHASEMI BOROUMAND4, KIANOUSH SHAHRAKI5 1Department of Ophthalmology, Alzahra Eye Hospital, Zahedan University of Medical Sciences, Zahedan, Iran 2Department of Optometry, School of Rehabilitation, Zahedan University of Medical Sciences, Zahedan, Iran 3Basir Eye Clinic, Tehran, Iran 4Shahid Beheshti University of Medical Sciences, Tehran, Iran 5Department of Ophthalmology, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran *Corresponding author: Mohammad Naeim Amini Fard; Department of Ophthalmology, Alzahra Eye Hospital, Zahedan University of Medical Sciences, Zahedan, Iran; Phone/Fax: +98 9124357993; E-mail: [email protected] (Received: January 25, 2017; Revised manuscript received: March 9, 2017; Accepted: March 13, 2017) Abstract: Background: Endophthalmitis is one of the most important complications after cataract surgery and in case event can cause many symptoms, such as severe decrease in eyesight and/or even the loss of vision. Employing methods to reduce this problem is very important. The aim of this study was to evaluate the effect of intracameral cefuroxime after cataract surgery on corneal endothelial cell counts and its morphology. Methods: In this study, 32 eyes of 30 patients underwent endothelial cell count and morphology assessment by ConfoScan III device before and 1 month after cataract surgery. All patients undertaken cataract surgery by one surgeon and by one method. Intracameral cefuroxime (1 mg/0.1 ml) was used as prophylaxis of postoperative endophthalmitis at the end of operation.
    [Show full text]
  • Adeno-Associated Virus Mediated Gene Therapy for Corneal Diseases
    pharmaceutics Review Adeno-Associated Virus Mediated Gene Therapy for Corneal Diseases Prabhakar Bastola 1,2 , Liujiang Song 1,2, Brian C. Gilger 1,3 and Matthew L. Hirsch 1,2,* 1 Ophthalmology, University of North Carolina, Chapel Hill, NC 27599, USA; [email protected] (P.B.); [email protected] (L.S.); [email protected] (B.C.G.) 2 Gene Therapy Center, University of North Carolina, Chapel Hill, NC 27599, USA 3 Clinical Sciences, North Carolina State University, Raleigh, NC 27695, USA * Correspondence: [email protected]; Tel.: +1-919-966-0696 Received: 10 July 2020; Accepted: 6 August 2020; Published: 13 August 2020 Abstract: According to the World Health Organization, corneal diseases are the fourth leading cause of blindness worldwide accounting for 5.1% of all ocular deficiencies. Current therapies for corneal diseases, which include eye drops, oral medications, corrective surgeries, and corneal transplantation are largely inadequate, have undesirable side effects including blindness, and can require life-long applications. Adeno-associated virus (AAV) mediated gene therapy is an optimistic strategy that involves the delivery of genetic material to target human diseases through gene augmentation, gene deletion, and/or gene editing. With two therapies already approved by the United States Food and Drug Administration and 200 ongoing clinical trials, recombinant AAV (rAAV) has emerged as the in vivo viral vector-of-choice to deliver genetic material to target human diseases. Likewise, the relative ease of applications through targeted delivery and its compartmental nature makes the cornea an enticing tissue for AAV mediated gene therapy applications. This current review seeks to summarize the development of AAV gene therapy, highlight preclinical efficacy studies, and discuss potential applications and challenges of this technology for targeting corneal diseases.
    [Show full text]
  • Characteristics of Corneal Dystrophies: a Review from Clinical, Histological and Genetic Perspectives
    Characteristicsofcornealdystrophies 窑Review窑 Characteristicsofcornealdystrophies:areviewfrom clinical,histologicalandgeneticperspectives DepartmentofOphthalmology,ShanghaiEastHospital, mechanismsremainunclearinmanycases.AlthoughCDs TongjiUniversitySchoolofMedicine,Shanghai200120, arestillenigmatic,ourknowledgeaboutthemhasbeen China expandedgreatlyinrecentyearsduetothedevelopmentof Correspondence to: Hong-PingCui.Departmentof genesequencingtechniquesand ophthalmological Ophthalmology,ShanghaiEastHospital,TongjiUniversity examinationadvances[ high-definitionopticalcoherence SchoolofMedicine,Shanghai200120,China.hpcui@vip. tomography(OCT),confocalmicroscopy].Thisreview 163.com highlightstheadvancesinourunderstandingofCDsbasedon Received:2015-07-19Accepted:2015-08-16 researchesinrecentyears. MATERIALSANDMETHODS Abstract SearchStrategy Toidentifytherelevantstudies,we searchedPubMedforpapersinvestigatingtheclinical · Cornealdystrophyisacommontypeofhereditary manifestations,histologyorgeneticsofCDs.Thesearchwas cornealdiseases.Itincludesmanytypes,whichhave throughMay2015withnolanguagerestrictions.Each variedpathology,histologyandclinicalmanifestations. subtypeofCDswassearchedseparately.Forexample,the Recently,theexaminationtechniquesofophthalmology andgenesequencingadvancegreatly,whichdobenefit searchingkeyitemsofABMDinclude:ABMD,epithelial toourunderstandingofthesediseases.However,many basementmembranedystrophy(EBMD),Coganmicrocystic aspectsremainstillunknown.Andduetothepoor dystrophy,map-dot-fingerprint(MDF)dystrophy,clinic, knowledgeofthesediseases,theresultsofthetreatments
    [Show full text]
  • Financial Disclosures Introduction Fuchs' Endothelial
    3/23/2016 Financial Disclosures None Laurence T. D. Sperber, MD Clinical Professor Residency Program Director Director, Cornea Service Department of Ophthalmology New York University School of Medicine 61st Annual Rochester Ophthalmology Conference Flaum Eye Institute, Rochester, NY Introduction Fuchs’ Endothelial Dystrophy Discussion of the decision-making process related to Preoperative evaluation performing cataract surgery in patients with corneal • Careful history disease • Slit lamp examination • Fuchs’ Endothelial Dystrophy • Pachymetry • Herpes Simplex Keratitis • Specular Microscopy • Keratoconus • Discussion of correction of post surgical refractive error Fuchs’ Endothelial Dystrophy Fuchs’ Endothelial Dystrophy Surgical decision-making Surgical decision-making • History - vision worse in AM, better as day progresses, • Specular Microscopy suggestive of corneal edema . Examination of endothelial cell morphology and number • Slit lamp exam - clinical edema . Cell count < 1000 cells/mm2 concerning • Epithelial Use as a guide - no set numbers necessitate performing triple procedure (DSAEK or DMEK/CE/IOL) • Stromal +/- Descemet’s Folds 1 3/23/2016 Fuchs’ Endothelial Dystrophy Fuchs’ Endothelial Dystrophy Surgical decision-making Surgical decision-making – no set numbers • Pachymetry - measurement of corneal thickness • Pachymetry < 0.6mm with no corneal edema by exam or hx . Excellent gauge of endothelial cell function • Cataract Extraction alone . Most useful in choice of surgical procedure • Pachymetry > 0.6 mm • Consider
    [Show full text]